Senores Pharmaceuticals IPO: A Comprehensive Guide for Investors
Overview of Senores Pharmaceuticals IPO
The Senores Pharmaceuticals IPO is a book-built issue with a total size of ₹582.11 crores. The offer includes a fresh issue of 1.28 crore shares worth ₹500 crores and an offer for sale of 21 lakh shares worth ₹82.11 crores. Investors have shown significant interest, with subscription levels soaring, especially in the retail category.
Senores Pharmaceuticals IPO Key Details
- IPO Opening Date: December 20, 2024
- IPO Closing Date: December 24, 2024
- Price Band: ₹372 to ₹391 per share
- Lot Size: 38 shares (minimum)
- Face Value: ₹10 per share
- Total Issue Size: ₹582.11 crores
- Listing Date: Tentatively December 30, 2024
- Bidding Type: Book Built Issue
- Listing Platforms: BSE, NSE
Senores Pharmaceuticals IPO Subscription Status (As of Day 2)
The IPO has already gained significant traction, with the overall subscription at 14.63 times by December 23, 2024. Here’s a breakdown of the categories:
- Qualified Institutional Buyers (QIB): 0.36 times
- Non-Institutional Investors (NII): 25.73 times
- Retail Investors: 40.25 times
This suggests strong retail investor interest, with significant oversubscription in the NII and retail categories.
Senores Pharmaceuticals IPO Price and Investment Details
- Price Band: ₹372 – ₹391 per share
- Minimum Lot Size: 38 shares
- Retail Minimum Investment: ₹14,858 (for 38 shares)
- NII Minimum Investment (sNII): ₹2,08,012 (for 532 shares)
- NII Minimum Investment (bNII): ₹10,10,344 (for 2,584 shares)
Senores Pharmaceuticals IPO GMP (Grey Market Premium)
As of now, the GMP (Grey Market Premium) for the Senores Pharmaceuticals IPO is highly anticipated, indicating positive sentiment in the market. Investors should monitor the IPO GMP closely for insights into potential listing gains.
Senores Pharmaceuticals IPO Allotment and Listing Details
The allotment process for the IPO will be finalized on December 26, 2024, with shares being credited to the demat accounts by December 27, 2024. The tentative listing date is set for December 30, 2024. It will be listed on both the BSE and NSE.
Senores Pharmaceuticals IPO Timeline (Tentative)
- IPO Opens: December 20, 2024
- IPO Closes: December 24, 2024
- Basis of Allotment: December 26, 2024
- Refunds Initiated: December 27, 2024
- Credit to Demat Accounts: December 27, 2024
- Listing Date: December 30, 2024
Investor Categories and Shares Offered
The Senores Pharmaceuticals IPO offers 1.48 crore shares, with the following reservation:
- QIB (Qualified Institutional Buyers): 44,43,817 shares (30% of the total offer)
- NII (Non-Institutional Investors): 22,21,909 shares (15%)
- Retail Investors (RII): 14,81,272 shares (10%)
- Anchor Investors: 66,65,725 shares (45%)
FAQs on Senores Pharmaceuticals IPO
1. What is the Senores Pharmaceuticals IPO price band?
The price band for the Senores Pharmaceuticals IPO is set between ₹372 and ₹391 per share.
2. When will the Senores Pharmaceuticals IPO allotment be finalized?
The allotment for the IPO will be finalized on December 26, 2024.
3. What is the expected listing date for the Senores Pharmaceuticals IPO?
The tentative listing date is December 30, 2024.
4. How much should I invest in the Senores Pharmaceuticals IPO?
The minimum investment required for retail investors is ₹14,858 (for 38 shares). Higher investments are required for HNIs.
5. What is the Senores Pharmaceuticals IPO GMP?
The Grey Market Premium (GMP) is a key indicator of the potential listing gains and is currently highly anticipated. Keep an eye on it for updates.
6. How can I apply for the Senores Pharmaceuticals IPO?
You can apply for the IPO through your demat account and UPI for retail applications, or through your broker for institutional applications.
Stay updated with Tap Invest for more IPO insights, investment opportunities, and expert guidance to help you make informed investment decisions.
